CompletedPhase 4NCT05460377

Assessing Immunogenicity of Intramuscular Sabin Inactivated Poliovirus Vaccine and Non-inferiority of Intradermal Fractional Inactivated Poliovirus Vaccine

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centers for Disease Control and Prevention
Principal Investigator
Khalequ Zaman, PhD
International Centre for Diarrhoeal Disease Research, Bangladesh
Intervention
Full dose Sabin Inactivated Poliovirus Vaccine produced by IMBCAMS(biological)
Enrollment
1224 target
Eligibility
All sexes
Timeline
2022 – 2024

Study locations (1)

Collaborators

International Centre for Diarrhoeal Disease Research, Bangladesh · World Health Organization · Centers for Disease Control and Prevention, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05460377 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis →

← Back to all trials